• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺血性脑卒中的神经元死亡机制和治疗策略。

Neuronal Death Mechanisms and Therapeutic Strategy in Ischemic Stroke.

机构信息

Department of Neurology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, 210008, China.

The State Key Laboratory of Pharmaceutical Biotechnology, Institute of Brain Science, Nanjing University, Nanjing, 210008, China.

出版信息

Neurosci Bull. 2022 Oct;38(10):1229-1247. doi: 10.1007/s12264-022-00859-0. Epub 2022 May 5.

DOI:10.1007/s12264-022-00859-0
PMID:35513682
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9554175/
Abstract

Ischemic stroke caused by intracranial vascular occlusion has become increasingly prevalent with considerable mortality and disability, which gravely burdens the global economy. Current relatively effective clinical treatments are limited to intravenous alteplase and thrombectomy. Even so, patients still benefit little due to the short therapeutic window and the risk of ischemia/reperfusion injury. It is therefore urgent to figure out the neuronal death mechanisms following ischemic stroke in order to develop new neuroprotective strategies. Regarding the pathogenesis, multiple pathological events trigger the activation of cell death pathways. Particular attention should be devoted to excitotoxicity, oxidative stress, and inflammatory responses. Thus, in this article, we first review the principal mechanisms underlying neuronal death mediated by these significant events, such as intrinsic and extrinsic apoptosis, ferroptosis, parthanatos, pyroptosis, necroptosis, and autophagic cell death. Then, we further discuss the possibility of interventions targeting these pathological events and summarize the present pharmacological achievements.

摘要

由颅内血管阻塞引起的缺血性脑卒中发病率日益增高,具有较高的死亡率和致残率,严重影响全球经济。目前相对有效的临床治疗方法仅限于静脉注射阿替普酶和血栓切除术。即使如此,由于治疗窗口期短和缺血/再灌注损伤的风险,患者仍然受益甚微。因此,迫切需要弄清楚缺血性脑卒中后的神经元死亡机制,以便开发新的神经保护策略。关于发病机制,多种病理事件引发细胞死亡途径的激活。特别需要关注兴奋性毒性、氧化应激和炎症反应。因此,在本文中,我们首先回顾了这些重要事件介导的神经元死亡的主要机制,如内在和外在凋亡、铁死亡、PARP 过度激活诱导的坏死、细胞焦亡、坏死性凋亡和自噬性细胞死亡。然后,我们进一步讨论了针对这些病理事件的干预的可能性,并总结了目前的药理学成就。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4b1/9554175/c91d4610be9c/12264_2022_859_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4b1/9554175/0edd6804b3e7/12264_2022_859_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4b1/9554175/90de2989468a/12264_2022_859_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4b1/9554175/3eaf219cd80a/12264_2022_859_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4b1/9554175/cdb03d50f99c/12264_2022_859_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4b1/9554175/8c7ede9d0fa5/12264_2022_859_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4b1/9554175/0d467574ccd5/12264_2022_859_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4b1/9554175/f418b7f34ad5/12264_2022_859_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4b1/9554175/c91d4610be9c/12264_2022_859_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4b1/9554175/0edd6804b3e7/12264_2022_859_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4b1/9554175/90de2989468a/12264_2022_859_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4b1/9554175/3eaf219cd80a/12264_2022_859_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4b1/9554175/cdb03d50f99c/12264_2022_859_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4b1/9554175/8c7ede9d0fa5/12264_2022_859_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4b1/9554175/0d467574ccd5/12264_2022_859_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4b1/9554175/f418b7f34ad5/12264_2022_859_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4b1/9554175/c91d4610be9c/12264_2022_859_Fig8_HTML.jpg

相似文献

1
Neuronal Death Mechanisms and Therapeutic Strategy in Ischemic Stroke.缺血性脑卒中的神经元死亡机制和治疗策略。
Neurosci Bull. 2022 Oct;38(10):1229-1247. doi: 10.1007/s12264-022-00859-0. Epub 2022 May 5.
2
Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implications.缺血性脑卒中神经元细胞死亡的机制及其治疗意义。
Med Res Rev. 2022 Jan;42(1):259-305. doi: 10.1002/med.21817. Epub 2021 May 6.
3
Cell Death Mechanisms in Cerebral Ischemia-Reperfusion Injury.脑缺血再灌注损伤中的细胞死亡机制。
Neurochem Res. 2022 Dec;47(12):3525-3542. doi: 10.1007/s11064-022-03697-8. Epub 2022 Aug 17.
4
An Updated Review of Mitochondrial Transplantation as a Potential Therapeutic Strategy Against Cerebral Ischemia and Cerebral Ischemia/Reperfusion Injury.线粒体移植作为一种针对脑缺血和脑缺血/再灌注损伤的潜在治疗策略的最新综述。
Mol Neurobiol. 2023 Apr;60(4):1865-1883. doi: 10.1007/s12035-022-03200-y. Epub 2023 Jan 3.
5
The Role of Necroptosis in Cerebral Ischemic Stroke.细胞坏死在脑缺血性脑卒中的作用。
Mol Neurobiol. 2024 Jul;61(7):3882-3898. doi: 10.1007/s12035-023-03728-7. Epub 2023 Dec 1.
6
Ferroptosis in ischemic stroke: Animal models and mechanisms.铁死亡在缺血性脑卒中中的作用:动物模型与机制。
Zool Res. 2024 Nov 18;45(6):1235-1248. doi: 10.24272/j.issn.2095-8137.2024.239.
7
Effect of Intra-arterial Alteplase vs Placebo Following Successful Thrombectomy on Functional Outcomes in Patients With Large Vessel Occlusion Acute Ischemic Stroke: The CHOICE Randomized Clinical Trial.成功取栓后动脉内注射阿替普酶与安慰剂对大血管闭塞性急性缺血性脑卒中患者功能结局的影响:CHOICE 随机临床试验。
JAMA. 2022 Mar 1;327(9):826-835. doi: 10.1001/jama.2022.1645.
8
β-Caryophyllene suppresses ferroptosis induced by cerebral ischemia reperfusion via activation of the NRF2/HO-1 signaling pathway in MCAO/R rats.β-石竹烯通过激活 MCAO/R 大鼠中的 NRF2/HO-1 信号通路抑制脑缺血再灌注诱导的铁死亡。
Phytomedicine. 2022 Jul 20;102:154112. doi: 10.1016/j.phymed.2022.154112. Epub 2022 Apr 22.
9
Receptors, Channel Proteins, and Enzymes Involved in Microglia-mediated Neuroinflammation and Treatments by Targeting Microglia in Ischemic Stroke.参与小胶质细胞介导的神经炎症的受体、通道蛋白和酶以及缺血性中风中靶向小胶质细胞的治疗方法。
Neuroscience. 2021 Apr 15;460:167-180. doi: 10.1016/j.neuroscience.2021.02.018. Epub 2021 Feb 18.
10
Rationale and design of combination of an immune modulator Fingolimod with Alteplase bridging with Mechanical Thrombectomy in Acute Ischemic Stroke (FAMTAIS) trial.联合免疫调节剂芬戈莫德和机械取栓桥接阿替普酶治疗急性缺血性脑卒中(FAMTAIS)试验的原理和设计。
Int J Stroke. 2017 Oct;12(8):906-909. doi: 10.1177/1747493017710340. Epub 2017 Jun 1.

引用本文的文献

1
Statins in Acute Ischemic Stroke: Mechanisms, Resistance, and Precision Strategies for Neurovascular and Cognitive Protection.急性缺血性卒中中的他汀类药物:神经血管和认知保护的机制、耐药性及精准策略
CNS Drugs. 2025 Sep 9. doi: 10.1007/s40263-025-01222-3.
2
Dynamic mechanisms and targeted interventions in cerebral ischemia-reperfusion injury: pathological cascade from ischemia to reperfusion and promising therapeutic strategies.脑缺血再灌注损伤的动态机制及靶向干预:从缺血到再灌注的病理级联反应及有前景的治疗策略
Front Neurosci. 2025 Aug 18;19:1649533. doi: 10.3389/fnins.2025.1649533. eCollection 2025.
3
Salvianolic Acid B and Ginsenoside Rg1 Combination Attenuates Cerebral Edema Accompanying Glymphatic Modulation.

本文引用的文献

1
A lithium-doped surface inspires immunomodulatory functions for enhanced osteointegration through PI3K/AKT signaling axis regulation.掺锂表面通过调节 PI3K/AKT 信号通路调节来激发免疫调节功能,从而增强骨整合。
Biomater Sci. 2021 Dec 7;9(24):8202-8220. doi: 10.1039/d1bm01075a.
2
Discovery of novel brain-penetrant GluN2B NMDAR antagonists via pharmacophore-merging strategy as anti-stroke therapeutic agents.通过药效团融合策略发现新型脑渗透性GluN2B NMDAR拮抗剂作为抗中风治疗药物。
Eur J Med Chem. 2022 Jan 5;227:113876. doi: 10.1016/j.ejmech.2021.113876. Epub 2021 Oct 8.
3
Targeted Treatment of Ischemic Stroke by Bioactive Nanoparticle-Derived Reactive Oxygen Species Responsive and Inflammation-Resolving Nanotherapies.
丹酚酸B与人参皂苷Rg1联合应用减轻伴随类淋巴系统调节的脑水肿。
Neurosci Bull. 2025 Aug 31. doi: 10.1007/s12264-025-01490-5.
4
Cerebral ischemia-reperfusion injury: mechanisms and promising therapies.脑缺血再灌注损伤:机制与前景广阔的治疗方法
Front Pharmacol. 2025 Jul 16;16:1613464. doi: 10.3389/fphar.2025.1613464. eCollection 2025.
5
A systematic review of silymarin and silibinin mechanisms for attenuating cerebral ischemia-reperfusion injuries.水飞蓟素和水飞蓟宾减轻脑缺血再灌注损伤机制的系统评价
Avicenna J Phytomed. 2025 Jul-Aug;15(4):1279-1297. doi: 10.22038/ajp.2024.25370.
6
Acteoside ameliorates cerebral ischemia/reperfusion injury in MCAO rats as a natural plasma Kallikrein inhibitor from Osmanthus fragrans flower.连翘酯苷作为一种来自桂花的天然血浆激肽释放酶抑制剂,可改善大脑中动脉闭塞(MCAO)大鼠的脑缺血/再灌注损伤。
Sci Rep. 2025 Jul 2;15(1):23509. doi: 10.1038/s41598-025-06553-1.
7
Exploration of shared diagnostic genes and mechanisms between crohn's disease and ischemic stroke by integrated comprehensive bioinformatics analysis and machine learning.通过综合生物信息学分析和机器学习探索克罗恩病与缺血性中风之间的共同诊断基因及机制
Mamm Genome. 2025 Jun 30. doi: 10.1007/s00335-025-10145-9.
8
Macluraparishin C Enhances Neuroprotection Against Oxidative Stress-Induced Neurodegeneration by Activating the Antioxidant/MAPK Signaling Pathway.Macluraparishin C通过激活抗氧化/MAPK信号通路增强对氧化应激诱导的神经退行性变的神经保护作用。
Mol Neurobiol. 2025 Jun 27. doi: 10.1007/s12035-025-05139-2.
9
Enhanced Therapeutic Effects of Extracellular Vesicles Targeting MiR-137 Contribute to Functional Recovery by Attenuating Neuronal Injury After Ischemic Stroke.靶向miR-137的细胞外囊泡增强治疗效果,通过减轻缺血性中风后神经元损伤促进功能恢复。
Neurosci Bull. 2025 Jun 23. doi: 10.1007/s12264-025-01437-w.
10
Hydroxysafflor Yellow A Ameliorates Ischemic Stroke by Inhibiting NLRP3, AIM2, and Pyrin Inflammasome-Mediated Pyroptosis.羟基红花黄色素A通过抑制NLRP3、AIM2和 Pyrin炎性小体介导的细胞焦亡改善缺血性脑卒中。
Neurochem Res. 2025 Jun 13;50(3):201. doi: 10.1007/s11064-025-04452-5.
靶向治疗缺血性脑卒中的生物活性纳米颗粒衍生的活性氧响应和炎症缓解纳米治疗。
ACS Nano. 2021 Oct 26;15(10):16076-16094. doi: 10.1021/acsnano.1c04753. Epub 2021 Oct 4.
4
Machine learning enables discovery of Gentianine targeting TLR4/NF-κB pathway to repair ischemic stroke injury.机器学习可发现龙胆苦苷靶向 TLR4/NF-κB 通路修复缺血性脑卒中损伤。
Pharmacol Res. 2021 Nov;173:105913. doi: 10.1016/j.phrs.2021.105913. Epub 2021 Sep 24.
5
PKM2 promotes neutrophil activation and cerebral thromboinflammation: therapeutic implications for ischemic stroke.PKM2 促进中性粒细胞激活和脑血栓炎症:对缺血性脑卒中的治疗意义。
Blood. 2022 Feb 24;139(8):1234-1245. doi: 10.1182/blood.2021012322.
6
Emerging Role of LncRNAs in Ischemic Stroke-Novel Insights into the Regulation of Inflammation.长链非编码RNA在缺血性脑卒中中的新作用——对炎症调节的新见解
J Inflamm Res. 2021 Sep 7;14:4467-4483. doi: 10.2147/JIR.S327291. eCollection 2021.
7
Transcriptome-Wide Analysis to Identify the Inflammatory Role of lncRNA in Experimental Ischemic Stroke.全转录组分析以确定lncRNA在实验性缺血性卒中中的炎症作用
J Inflamm Res. 2021 Jun 22;14:2667-2680. doi: 10.2147/JIR.S315281. eCollection 2021.
8
Ferroptosis and Its Multifaceted Roles in Cerebral Stroke.铁死亡及其在脑卒中介导的多方面作用
Front Cell Neurosci. 2021 Jun 3;15:615372. doi: 10.3389/fncel.2021.615372. eCollection 2021.
9
A novel cell-penetrating peptide targeting calpain-cleavage of PSD-95 induced by excitotoxicity improves neurological outcome after stroke.一种新型细胞穿透肽靶向钙蛋白酶切割兴奋毒性诱导的 PSD-95,改善中风后的神经功能结局。
Theranostics. 2021 May 3;11(14):6746-6765. doi: 10.7150/thno.60701. eCollection 2021.
10
TNF-α Receptor Inhibitor Alleviates Metabolic and Inflammatory Changes in a Rat Model of Ischemic Stroke.肿瘤坏死因子-α受体抑制剂减轻缺血性脑卒中大鼠模型的代谢和炎症变化。
Antioxidants (Basel). 2021 May 26;10(6):851. doi: 10.3390/antiox10060851.